Research progress on the disease burden of influenza in China
LI Wen-juan1,WANG Da-yan2
1.School of Forensic and Laboratory Medicine, Jining Medical University, Jining 272067, China; 2.Chinese National Influenza Center, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention;WHO Collaborating Center for Reference and Research on Influenza;Beijing 102206, China
Abstract：Influenza, an acute respiratory infectious disease worldwide, generate increased burden on human health, healthcare utilization and substantial socio-economic burden on families and society. The analysis of disease burden associated with influenza is of great significance for the adjustment of vaccination strategies and optimization of the allocation of public health resources. In this paper, relevant articles and official reports were searched focusing on the disease burden of influenza in China in recent years, aiming to reflect the impact of influenza on human health and social economy comprehensively and provide proof for the prevention and control policies on influenza,these findings highlight the possible value of an in fluenza vaccination program.
李文娟, 王大燕. 我国流感疾病负担相关研究进展[J]. 中国人兽共患病学报, 2019, 35(10): 928-933.
LI Wen-juan,WANG Da-yan. Research progress on the disease burden of influenza in China. Chinese Journal of Zoonoses, 2019, 35(10): 928-933.
[1] WHO. Up to 650 000 people die of respiratory diseases linked to seasonal flu each year[EB/OL].(2017-12-14)[2018-06-27].http://www.who.int/mediacentre/news/releases/2017/seasonal-flu/en/ [2] 国家卫生和健康委员会.传染病预防控制[EB/OL].[2018-06-27].http://www.nhfpc.gov.cn/jkj/s3578/new_list.shtml [3] WHO. FluNet[EB/OL]. [2018-06-27].http://www.who.int/influenza/gisrs_laboratory/flunet/en/ [4] 舒跃龙. 流感监测的发展历史及思考[J]. 中华流行病学杂志, 2011,32 (4):334-336. [5] Guo RN, Zheng HZ, Huang LQ, et al. Epidemiologic and economic burden of influenza in the outpatient setting: a prospective study in a subtropical area of China[J]. PLoS One,2012,7(7):e41403. DOI: 10.1371/journal.pone.0041403 [6] 李越. 基于哨点医院病原学监测和社区调查的流感疾病负担研究[D].北京:中国疾病预防控制中心,2016. [7] 陈涛,杨静,汪立杰,等.2016-2017年度中国大陆流行性感冒监测分析[J].中国人兽共患病学报,2018,34(03):193-199. DOI:10.3969/j.issn.1002-2694.2018.00.036 [8] Wu S, VAN Asten L, Wang L, et al. Estimated incidence and number of outpatient visits for seasonal influenza in 2015－2016 in Beijing, China[J]. Epidemiol Infect, 2017, 145(16):3334-3344. DOI:10.1017/S0950268817002369 [9] Wu S, Wei Z, Greene CM, et al. Mortality burden from seasonal influenza and 2009 H1N1 pandemic influenza in Beijing, China, 2007-2013[J].Influenza Other Respir Viruses,2018,12(1):88-97. DOI:10.1111/irv.12515 [10] Feng L, Shay DK, Jiang Y, et al. Influenza-associated mortality in temperate and subtropical Chinese cities, 2003-2008[J]. Bull World Health Organ,2012, 90(4):279-288B. DOI:10.2471/BLT.11.096958 [11] Wang H, Fu C, Li K, et al. Influenza associated mortality in Southern China, 2010－2012[J].Vaccine,2014, 32(8):973-978. DOI:10.1016/j.vaccine.2013.12.013 [12] Chan YK, Wong RY, Ip M, et al. Economic outcomes of influenza in hospitalized elderly with and without ICU admission[J]. Antivir Ther,2017, 22(2):173-177. DOI:10.3851/IMP3102 [13] Wu P, Presanis AM, Bond HS, et al. A joint analysis of influenza-associated hospitalizations and mortality in Hong Kong, 1998－2013[J].Sci Rep, 2017, 20;7(1):929. DOI:10.1038/s41598-017-01021-x [14] 胡爱香.上海市2000-2006年季节性流感超额死亡率研究[D].合肥:安徽医科大学,2008. [15] Yang L, Ma S, Chen PY, et al. Influenza associated mortality in the subtropics and tropics: results from three Asian cities [J].Vaccine, 2011, 29(48):8909-8914. DOI:10.1016/j.vaccine.2011.09.071 [16] Liu XX, Qin G, Li X, et al. Excess mortality associated with influenza after the 2009 H1N1 pandemic in a subtropical city in China, 2010-2015[J].Int J Infect Dis, 2017, 57:54-60. DOI:10.1016/j.ijid.2017.01.039 [17] Zhang H, Xiong Q, Wu P, et al. Influenza-associated mortality in Yancheng, China, 2011-15[J]. Influenza Other Respir Viruses,2018, 12 (1):98-103. DOI:10.1111/irv.12487 [18] Wong CM, Yang L, Chan E, et al. Influenza-associated hospitalisation[J]. Hong Kong Med J,2009, 15 (6): 35-37. [19] Zhang T, Zhang J, Hua J, et al. Influenza-associated outpatient visits among children less than 5 years of age in eastern China, 2011-2014[J]. BMC Infect Dis,2016, 16: 267. DOI:10.1186/s12879-016-1614-z [20] Wang D, Zhang T, Wu J, et al.Socio-economic burden of influenza among children younger than 5 years in the outpatient setting in Suzhou, China[J]. PLoS One,2013, 8(8):e69035. DOI:10.1371/journal.pone.0069035 [21] 王丹.苏州地区门诊5岁以下儿童流感流行病学和疾病负担研究[D].上海:复旦大学,2014. [22] Zhang X, Zhang J, Chen L, et al. Pneumonia and influenza hospitalizations among children under 5 years of age in Suzhou, China, 2005-2011[J].Influenza Other Respir Viruses,2017, 11(1):15-22. DOI:10.1111/irv.12405 [23] Zhang T, Zhu Q, Zhang X, et al. The clinical characteristics and direct medical cost of influenza in hospitalized children: a five-year retrospective study in Suzhou, China[J]. PLoS One, 2012, 7(9):e44391. DOI:10.1371/journal.pone.0044391 [24] Zhou L, Situ S, Huang T, et al. Direct medical cost of influenza-related hospitalizations among severe acute respiratory infections cases in three provinces in China [J]. PLoS One, 2013, 22;8(5):e63788. DOI:10.1371/journal.pone.0063788 [25] Chan YK, Wong RY, Ip M, et al. Economic outcomes of influenza in hospitalized elderly with and without ICU admission [J]. Antivir Ther,2017, 22(2):173-177. DOI:10.3851/IMP3102 [26] Yang J, Jit M, Leung KS, et al.The economic burden of influenza-associated outpatient visits and hospitalizations in China: a retrospective survey [J]. Infect Dis Poverty, 2015,4:44. DOI:10.1186/s40249-015-0077-6 [27] Yang P, Thompson MG, Ma C, et al. Influenza vaccine effectiveness against medically-attended influenza illness during the 2012-2013 season in Beijing, China[J]. Vaccine,2014, 32(41):5285-5289. DOI:10.1016/j.vaccine.2014.07.083 [28] 杨桂月,潘兴强,赵芬,等.中国老年人群流行性感冒疫苗保护效果的Meta分析[J].预防医学,2017,29(06):555-561. [29] Wang Y, Zhang T, Chen L, et al. Seasonal influenza vaccine effectiveness against medically attended influenza illness among children aged 6-59 months, October 2011-September 2012: A matched test-negative case-control study in Suzhou, China [J]. Vaccine, 2016, 34(21):2460-2465. DOI:10.1016/j .vaccine.2016.03.056 [30] Zhou L, Situ S, Feng Z, et al. Cost-effectiveness of alternative strategies for annual influenza vaccination among children aged 6 months to 14 years in four provinces in China[J]. PLoS One,2014, 9(1):e87590. DOI:10.1371/journal.pone.0087590 [31] 伊赫亚,冯录召,杨维中.流感免疫策略专家研讨会会议纪要[J].中国病毒病杂志,2017,7(6):401-404. [32] World Health Organization. Infographic e WHO recommends 75% of the elderly are vaccinated against seasonal inflfluenza[S]. Geneva: World Health Organization. Available at: http://www.euro.who.int/en/health-topics/communicable-diseases/inflfluenza/data-and-statistics/infographic-who-recommends-75-of-the-elderly-are-vaccinated-against-seasonal-influenza download; 2013 (last accessed February 2016). [33] Li T, Lv M, Lei T, et al.Who benefits most from influenza vaccination policy: a study among the elderly in Beijing, China[J]. Int J Equity Health,2016,15:45. DOI:10.1186/s12939-016-0332-x [34] Zhang Y, Wu SS, Yang P, et al. Association between socio-economic status indicators andadoption of preventive measures for influenza among Beijing residents across-sectional study [J]. Public Health, 2016, 140: 282-285. DOI:10.1016/j.puhe.2016.05.022 [35] 陈海平,翟力军,马燕丽,等.北京市流感病毒疫苗上市后接种率影响因素及安全性分析[J].中国生物制品学杂志,2016, 29(07):729-732. [36] Hu Y, Chen Y, Zhang B, et al. Two-dose seasonal influenza vaccine coverage and timeliness among children aged 6 months through 3 years: An evidence from the 2010-11 to the 2014-15 seasons in Zhejiang province, east China[J]. Hum Vaccin Immunother,2017,13 (1):75-80. DOI:10.1080/21645515.2016.1225640 [37] Yu H, Alonso WJ, Feng L, et al. Characterization of regional influenza seasonality patterns in China and implications for vaccination strategies: spatio-temporal modeling of surveillance data [J]. PLoS Med, 2013, 10(11):e1001552. DOI:10.1371/journal.pmed.1001552 [38] You JH, Ming WK, Chan PK. Cost-effectiveness of quadrivalent influenza vaccine in Hong Kong- A decision analysis [J]. Hum Vaccin Immunother,2015, 11(3):564-571. DOI:10.1080/21645515.2015.1011016 [39] 冯录召,彭质斌,王大燕,等.中国流感疫苗预防接种技术指南(2018-2019)[J].中华流行病学杂志,2018,39(11):1413-1425.
2019, Vol. 35 
